nach oben

Current Diabetes Reports

Erschienen in:

01.12.2015 | Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (E Mayer-Davis and C Shay, Section Editors)

Challenges and Opportunities in the Management of Cardiovascular Risk Factors in Youth With Type 1 Diabetes: Lifestyle and Beyond

verfasst von: Michelle Katz, Elisa Giani, Lori Laffel

Erschienen in: Current Diabetes Reports | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in persons with type 1 diabetes (T1D). Specific risk factors associated with diabetes, such as hyperglycemia and kidney disease, have been demonstrated to increase the incidence and progression of CVD. Nevertheless, few data exist on the effects of traditional risk factors such as dyslipidemia, obesity, and hypertension on CVD risk in youth with T1D. Improvements in understanding and approaches to the evaluation and management of CVD risk factors, specifically for young persons with T1D, are desirable. Recent advances in noninvasive techniques to detect early vascular damage, such as the evaluation of endothelial dysfunction and aortic or carotid intima-media thickness, provide new tools to evaluate the progression of CVD in childhood. In the present review, current CVD risk factor management, challenges, and potential therapeutic interventions in youth with T1D are described.

Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care. 1999;22(1):99–111.CrossRef

Soedamah-Muthu SS, Chaturvedi N, Witte DR, et al. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care. 2008;31(7):1360–6.PubMedCentralPubMedCrossRef

3.••

Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371(21):1972–82. This study provides data on the excess risk of death according to the level of glycemic control from the Swedish National Diabetes Register. PubMedCrossRef

Berenson GS. Childhood risk factors predict adult risk associated with subclinical cardiovascular disease. The Bogalusa Heart Study. Am J Cardiol. 2002;90(10C):3L–7.PubMedCrossRef

Eltayeb AA, Ahmad FA, Sayed DM, Osama AM. Subclinical vascular endothelial dysfunctions and myocardial changes with type 1 diabetes mellitus in children and adolescents. Pediatr Cardiol. 2014;35(6):965–74.PubMedCrossRef

6.•

Harjutsalo V, Maric-Bilkan C, Forsblom C, Groop PH. Impact of sex and age at onset of diabetes on mortality from ischemic heart disease in patients with type 1 diabetes. Diabetes Care. 2014;37(1):144–8. This study demonstrates the impact of gender as a risk factor for ischemic heart disease. PubMedCrossRef

7.••

Orchard TJ, Nathan DM, Zinman B, et al. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA. 2015;313(1):45–53. This study investigates the impact of insulin intensive therapy on mortality in the long-term follow-up of the DCCT cohort. PubMedCentralPubMedCrossRef

Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643–53.PubMedCrossRef

Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 diabetes and coronary artery disease. Diabetes Care. 2006;29(11):2528–38.PubMedCrossRef

10.

Fullerton B, Jeitler K, Seitz M, et al. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2014;2, CD009122.PubMed

11.

Torffvit O, Lovestam-Adrian M, Agardh E, Agardh CD. Nephropathy, but not retinopathy, is associated with the development of heart disease in type 1 diabetes: a 12-year observation study of 462 patients. Diabet Med. 2005;22(6):723–9.PubMedCrossRef

12.

Secrest AM, Becker DJ, Kelsey SF, LaPorte RE, Orchard TJ. Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes. 2010;59(12):3216–22.PubMedCentralPubMedCrossRef

13.

Groop PH, Thomas MC, Moran JL, et al. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes. 2009;58(7):1651–8.PubMedCentralPubMedCrossRef

14.

Daniels M, Dubose SN, Maahs DM, et al. Factors associated with microalbuminuria in 7,549 children and adolescents with type 1 diabetes in the T1D Exchange Clinic Registry. Diabetes Care. 2013;36(9):2639–45.PubMedCentralPubMedCrossRef

15.

Chiang JL, Kirkman MS, Laffel LM, Peters AL. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care. 2014;37(7):2034–54.PubMedCrossRef

16.

International Society for Pediatric and Adolescent Diabetes (ISPAD). ISPAD consensus guidelines for the management of type 1 diabetes mellitus in children and adolescents. 2000. Ed.PGF Swift.Publ.Medforum, Zeist, Netherlands.

17.

Wood JR, Miller KM, Maahs DM, et al. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care. 2013;36(7):2035–7.PubMedCentralPubMedCrossRef

18.

Petitti DB, Klingensmith GJ, Bell RA, et al. Glycemic control in youth with diabetes: the SEARCH for Diabetes in Youth Study. J Pediatr. 2009;155(5):668–72.PubMedPubMedCentralCrossRef

19.

Gerstl EM, Rabl W, Rosenbauer J, et al. Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade. Eur J Pediatr. 2008;167(4):447–53.PubMedCrossRef

20.

Clements MA, Foster NC, Maahs DM, et al. Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D Exchange Clinic Registry. Pediatr Diabetes. 2015;12:1579–82.

21.

Miller KM, Beck RW, Bergenstal RM, et al. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D Exchange Clinic Registry participants. Diabetes Care. 2013;36(7):2009–14.PubMedCentralPubMedCrossRef

22.

Skupien J, Warram JH, Smiles A, et al. Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria. J Am Soc Nephrol. 2014;25(12):2916–25.PubMedPubMedCentralCrossRef

23.

Laffel LM, Vangsness L, Connell A, et al. Impact of ambulatory, family-focused teamwork intervention on glycemic control in youth with type 1 diabetes. J Pediatr. 2003;142(4):409–16.PubMedCrossRef

24.

Katz ML, Volkening LK, Butler DA, Anderson BJ, Laffel LM. Family-based psychoeducation and Care Ambassador intervention to improve glycemic control in youth with type 1 diabetes: a randomized trial. Pediatr Diabetes. 2014;15(2):142–50.PubMedCentralPubMedCrossRef

25.

Hood KK, Rohan JM, Peterson CM, Drotar D. Interventions with adherence-promoting components in pediatric type 1 diabetes: meta-analysis of their impact on glycemic control. Diabetes Care. 2010;33(7):1658–64.PubMedCentralPubMedCrossRef

26.

Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311–20.PubMedCrossRef

27.

Dauber A, Corcia L, Safer J, et al. Closed-loop insulin therapy improves glycemic control in children aged <7 years: a randomized controlled trial. Diabetes Care. 2013;36(2):222–7.PubMedCentralPubMedCrossRef

28.

Hovorka R, Elleri D, Thabit H, et al. Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care. 2014;37(5):1204–11.PubMedCentralPubMedCrossRef

29.

Guy J, Ogden L, Wadwa RP, et al. Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study. Diabetes Care. 2009;32(3):416–20.PubMedCentralPubMedCrossRef

30.•

Maahs DM, Dabelea D, D’Agostino Jr RB, et al. Glucose control predicts 2-year change in lipid profile in youth with type 1 diabetes. J Pediatr. 2013;162(1):101–7. This epidemiological study describes how changes in glucose control impact changes in the lipid profile in a large cohort of youth with T1D participating in the SEARCH study. PubMedCrossRef

31.

Reh CM, Mittelman SD, Wee CP, et al. A longitudinal assessment of lipids in youth with type 1 diabetes. Pediatr Diabetes. 2011;12(4 Pt 2):365–71.PubMed

32.

Expert panel on integrated guidelines for cardiovascular health and risk reduction in Children and Adolescents. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128 Suppl 5:S213–56.PubMedCentralCrossRef

33.

American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38 Suppl 1:S5–87.CrossRef

34.

Kavey RE, Daniels SR, Lauer RM, et al. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation. 2003;107(11):1562–6.PubMedCrossRef

35.

Orchard TJ, Forrest KY, Kuller LH, Becker DJ. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 2001;24(6):1053–9.PubMedCrossRef

36.

Obarzanek E, Kimm SY, Barton BA, et al. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). Pediatrics. 2001;107(2):256–64.PubMedCrossRef

37.

Kelishadi R, Hashemipour M, Mohammadifard N, Alikhassy H, Adeli K. Short- and long-term relationships of serum ghrelin with changes in body composition and the metabolic syndrome in prepubescent obese children following two different weight loss programmes. Clin Endocrinol (Oxf). 2008;69(5):721–9.CrossRef

38.

Eagle TF, Gurm R, Smith CA, et al. A middle school intervention to improve health behaviors and reduce cardiac risk factors. Am J Med. 2013;126(10):903–8.PubMedCrossRef

39.

Savoye M, Nowicka P, Shaw M, et al. Long-term results of an obesity program in an ethnically diverse pediatric population. Pediatrics. 2011;127(3):402–10.PubMedCentralPubMedCrossRef

40.

Wong K, Potter A, Mulvaney S, et al. Pediatric endocrinologists’ management of children with type 2 diabetes. Diabetes Care. 2010;33(3):512–4.PubMedCentralPubMedCrossRef

41.

Kershnar AK, Daniels SR, Imperatore G, et al. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study. J Pediatr. 2006;149(3):314–9.PubMedCrossRef

42.

Margeirsdottir HD, Larsen JR, Brunborg C, Overby NC, Dahl-Jorgensen K. High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study. Diabetologia. 2008;51(4):554–61.PubMedCrossRef

43.

Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S1–45.PubMedCrossRef

44.

Adolescent Type 1 Diabetes Cardio-renal Intervention Trial (AdDIT) BMC Pediatr 2009; 9:79.

45.

Adolescent Type 1 Diabetes Intervention Trial (AdDIT). 2015. doi: http://www.addit-trial.org/latest.html. Accessed: 9 Jul 2015.

46.•

Frohlich-Reiterer EE, Rosenbauer J, Bechtold-Dalla PS, et al. Predictors of increasing BMI during the course of diabetes in children and adolescents with type 1 diabetes: data from the German/Austrian DPV multicentre survey. Arch Dis Child. 2014;99(8):738–43. This study addresses risk factors for the increase in BMI during the course of diabetes. PubMedCrossRef

47.

Hanas R, Laffel L, Domenger C, et al. Lifestyle factors associated with glycemic control in youth with type 1 diabetes (T1D): the Global TEENs Study. Pediatr Diabetes. 2014;19:20.

48.

Liu LL, Lawrence JM, Davis C, et al. Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth Study. Pediatr Diabetes. 2010;11(1):4–11.PubMedCrossRef

49.

Lake A, Townshend T. Obesogenic environments: exploring the built and food environments. J R Soc Promot Health. 2006;126(6):262–7.PubMedCrossRef

50.

Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ. Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care. 2003;26(10):2871–5.PubMedCrossRef

51.

American Diabetes Association. Implications of the Diabetes Control and Complications Trial. Diabetes. 1993;42(11):1555–8.CrossRef

52.•

Purnell JQ, Zinman B, Brunzell JD. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study. Circulation. 2013;127(2):180–7. This study demonstrates the associations of excess weight gain with sustained increases in central obesity, insulin resistance, dyslipidemia, and blood pressure as well as more extensive atherosclerosis during the EDIC follow-up study. PubMedCrossRef

53.•

Baskaran C, Volkening LK, Diaz M, Laffel LM. A decade of temporal trends in overweight/obesity in youth with type 1 diabetes after the Diabetes Control and Complications Trial. Pediatr Diabetes. 2015;16(4):263–70. This study demonstrates stable trends of overweight/obesity in youth with T1D over a 10-year period. PubMedCrossRef

54.

Mayer-Davis EJ, Nichols M, Liese AD, et al. Dietary intake among youth with diabetes: the SEARCH for Diabetes in Youth Study. J Am Diet Assoc. 2006;106(5):689–97.PubMedCrossRef

55.•

Mehta SN, Volkening LK, Quinn N, Laffel LM. Intensively managed young children with type 1 diabetes consume high-fat, low-fiber diets similar to age-matched controls. Nutr Res. 2014;34(5):428–35. This study compared dietary intake in youth with T1D versus general US youth, demonstrating that young children with T1D consume high-fat, low-fiber diets compared to the general population. PubMedCentralPubMedCrossRef

56.

Patton SR, Dolan LM, Powers SW. Dietary adherence and associated glycemic control in families of young children with type 1 diabetes. J Am Diet Assoc. 2007;107(1):46–52.PubMedCrossRef

57.

Mehta SN, Haynie DL, Higgins LA, et al. Emphasis on carbohydrates may negatively influence dietary patterns in youth with type 1 diabetes. Diabetes Care. 2009;32(12):2174–6.PubMedCentralPubMedCrossRef

58.

Minges KE, Magliano DJ, Owen N, et al. Associations of strength training with impaired glucose metabolism: the AusDiab Study. Med Sci Sports Exerc. 2013;45(2):299–303.PubMedCrossRef

59.

Nansel TR, Laffel LM, Haynie DL, et al. Improving dietary quality in youth with type 1 diabetes: randomized clinical trial of a family-based behavioral intervention. Int J Behav Nutr Phys Act. 2015;12:58.PubMedCentralPubMedCrossRef

60.

Markowitz JT, Schultz AT, Cousineau TM, Franko DL, Laffel LMB. Mobile health (mHealth) intervention using text messaging aimed at healthy lifestyles for youth with diabetes (DM): a pilot randomized controlled trial (RCT).J Diabetes Sci Technol. 2014;8(5):1029–34.

61.•

Pivovarov JA, Taplin CE, Riddell MC. Current perspectives on physical activity and exercise for youth with diabetes. Pediatr Diabetes. 2015;16(4):242–55. This review highlights benefits and barriers of physical activity in youth with T1D and presents a new algorithm for the management of insulin therapy during sport activity. PubMedCrossRef

62.

Quirk H, Blake H, Tennyson R, Randell TL, Glazebrook C. Physical activity interventions in children and young people with type 1 diabetes mellitus: a systematic review with meta-analysis. Diabet Med. 2014;31(10):1163–73.PubMedCentralPubMedCrossRef

63.

Colberg SR, Sigal RJ, Fernhall B, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010;33(12):e147–67.PubMedCentralPubMedCrossRef

64.

Tamborlane WV. Triple jeopardy: nocturnal hypoglycemia after exercise in the young with diabetes. J Clin Endocrinol Metab. 2007;92(3):815–6.PubMedCrossRef

65.

Taplin CE, Cobry E, Messer L, et al. Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes. J Pediatr. 2010;157(5):784–8.PubMedCentralPubMedCrossRef

66.

Riddell MC, Milliken J. Preventing exercise-induced hypoglycemia in type 1 diabetes using real-time continuous glucose monitoring and a new carbohydrate intake algorithm: an observational field study. Diabetes Technol Ther. 2011;13(8):819–25.PubMedCrossRef

67.

Garg S, Brazg RL, Bailey TS, et al. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther. 2012;14(3):205–9.PubMedCrossRef

68.

Polsky S, Ellis SL. Obesity, insulin resistance, and type 1 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes. 2015;22(4):277–82.PubMedCrossRef

69.

Libman I, Miller KM, DiMeglio LA, et al. Metformin as an adjunct therapy does not improve glycemic control among overweight adolescents with type 1 diabetes (T1D) [abstract]. Endocr Rev. 2015;36(2 (Suppl)):OR01–5.

70.

Rodriguez BL, Dabelea D, Liese AD, et al. Prevalence and correlates of elevated blood pressure in youth with diabetes mellitus: the SEARCH for Diabetes in Youth Study. J Pediatr. 2010;157(2):245–51.PubMedCrossRef

71.•

Nambam B, Dubose SN, Nathan BM et al. Therapeutic inertia: underdiagnosed and undertreated hypertension in children participating in the T1D Exchange Clinic Registry. Pediatr Diabetes 2014. This study demonstrates the under-recognition and under-treatment of elevated blood pressure in youth with T1D being managed at pediatric diabetes centers.

72.

Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA. 2007;298(8):874–9.PubMedCrossRef

73.

Pedrosa C, Oliveira BM, Albuquerque I, et al. Markers of metabolic syndrome in obese children before and after 1-year lifestyle intervention program. Eur J Nutr. 2011;50(6):391–400.PubMedCrossRef

74.

Short KR, Blackett PR, Gardner AW, Copeland KC. Vascular health in children and adolescents: effects of obesity and diabetes. Vasc Health Risk Manag. 2009;5:973–90.PubMedCentralPubMed

75.

Jarvisalo MJ, Putto-Laurila A, Jartti L, et al. Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes. 2002;51(2):493–8.PubMedCrossRef

76.

Juonala M, Viikari JS, Kahonen M, et al. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study. J Am Coll Cardiol. 2008;52(4):293–9.PubMedCrossRef

77.

Widlansky ME, Gokce N, Keaney Jr JF, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42(7):1149–60.PubMedCrossRef

78.

Halcox JP, Donald AE, Ellins E, et al. Endothelial function predicts progression of carotid intima-media thickness. Circulation. 2009;119(7):1005–12.PubMedCrossRef

79.

Jarvisalo MJ, Raitakari M, Toikka JO, et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation. 2004;109(14):1750–5.PubMedCrossRef

80.

Bertoluci MC, Ce GV, da Silva AM, et al. Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes. World J Diabetes. 2015;6(5):679–92.PubMedCentralPubMedCrossRef

81.

Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond). 2005;109(2):143–59.CrossRef

82.

Haller MJ, Stein J, Shuster J, et al. Peripheral artery tonometry demonstrates altered endothelial function in children with type 1 diabetes. Pediatr Diabetes. 2007;8(4):193–8.PubMedCrossRef

83.

King GL, Loeken MR. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol. 2004;122(4):333–8.PubMedCrossRef

84.

Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res. 2009;335(1):165–89.PubMedCrossRef

85.

Faienza MF, Acquafredda A, Tesse R, et al. Risk factors for subclinical atherosclerosis in diabetic and obese children. Int J Med Sci. 2013;10(3):338–43.PubMedCentralPubMedCrossRef

86.•

Maftei O, Pena AS, Sullivan T, et al. Early atherosclerosis relates to urinary albumin excretion and cardiovascular risk factors in adolescents with type 1 diabetes: Adolescent Type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). Diabetes Care. 2014;37(11):3069–75. This study demonstrates the correlation between high urinary albumin excretion and early atherosclerosis detected by aortic intima-media thickness in youth with T1D. PubMedCrossRef

87.

Cohn JN, Quyyumi AA, Hollenberg NK, Jamerson KA. Surrogate markers for cardiovascular disease: functional markers. Circulation. 2004;109(25 Suppl 1):IV31–46.PubMed

88.

Laurent S, Cockcroft J, Van BL, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588–605.PubMedCrossRef

89.

Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318–27.PubMedCrossRef

90.

Shah AS, Wadwa RP, Dabelea D, et al. Arterial stiffness in adolescents and young adults with and without type 1 diabetes: the SEARCH CVD study. Pediatr Diabetes. 2015;16(5):367–74.PubMedCrossRef

91.

Haller MJ, Samyn M, Nichols WW, et al. Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes. Diabetes Care. 2004;27(12):2911–7.PubMedCrossRef

92.

Palombo C, Kozakova M, Morizzo C, et al. Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated type 1 diabetes. Cardiovasc Diabetol. 2011;10:88.PubMedCentralPubMedCrossRef

93.

Ce GV, Rohde LE, da Silva AM, et al. Endothelial dysfunction is related to poor glycemic control in adolescents with type 1 diabetes under 5 years of disease: evidence of metabolic memory. J Clin Endocrinol Metab. 2011;96(5):1493–9.PubMedCrossRef

94.

Ceriello A, Esposito K, Ihnat M, Thorpe J, Giugliano D. Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes. J Clin Endocrinol Metab. 2009;94(8):2751–6.PubMedCrossRef

95.

Franklin VL, Khan F, Kennedy G, Belch JJ, Greene SA. Intensive insulin therapy improves endothelial function and microvascular reactivity in young people with type 1 diabetes. Diabetologia. 2008;51(2):353–60.PubMedCrossRef

96.

Tonstad S, Joakimsen O, Stensland-Bugge E, et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler, Thromb, Vasc Biol. 1996;16(8):984–91.CrossRef

97.

Margeirsdottir HD, Stensaeth KH, Larsen JR, Brunborg C, Dahl-Jorgensen K. Early signs of atherosclerosis in diabetic children on intensive insulin treatment: a population-based study. Diabetes Care. 2010;33(9):2043–8.PubMedCentralPubMedCrossRef

98.

Lamotte C, Iliescu C, Libersa C, Gottrand F. Increased intima-media thickness of the carotid artery in childhood: a systematic review of observational studies. Eur J Pediatr. 2011;170(6):719–29.PubMedCrossRef

99.

Aggoun Y. Obesity, metabolic syndrome, and cardiovascular disease. Pediatr Res. 2007;61(6):653–9.PubMedCrossRef

100.

Caballero AE, Bousquet-Santos K, Robles-Osorio L, et al. Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance. Diabetes Care. 2008;31(3):576–82.PubMedCrossRef

101.

Aggoun Y, Szezepanski I, Bonnet D. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events in children. Pediatr Res. 2005;58(2):173–8.PubMedCrossRef

102.

Kapiotis S, Holzer G, Schaller G, et al. A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler, Thromb, Vasc Biol. 2006;26(11):2541–6.CrossRef

103.

Tounian P, Aggoun Y, Dubern B, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet. 2001;358(9291):1400–4.PubMedCrossRef

104.

Pena AS, Wiltshire E, MacKenzie K, et al. Vascular endothelial and smooth muscle function relates to body mass index and glucose in obese and nonobese children. J Clin Endocrinol Metab. 2006;91(11):4467–71.PubMedCrossRef

105.

Reinehr T, Kiess W, de Sousa G, Stoffel-Wagner B, Wunsch R. Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism. 2006;55(1):113–8.PubMedCrossRef

106.

Hilliard ME, Wu YP, Rausch J, Dolan LM, Hood KK. Predictors of deteriorations in diabetes management and control in adolescents with type 1 diabetes. J Adolesc Health. 2013;52(1):28–34.PubMedCentralPubMedCrossRef

107.

Willi SM, Miller KM, DiMeglio LA, et al. Racial-ethnic disparities in management and outcomes among children with type 1 diabetes. Pediatrics. 2015;135(3):424–34.PubMedCrossRef

Titel: Challenges and Opportunities in the Management of Cardiovascular Risk Factors in Youth With Type 1 Diabetes: Lifestyle and Beyond
verfasst von: Michelle Katz
Elisa Giani
Lori Laffel
Publikationsdatum: 01.12.2015
Verlag: Springer US
Erschienen in: Current Diabetes Reports / Ausgabe 12/2015
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-015-0692-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2015

Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic Origin

Undiagnosed MODY: Time for Action

Molecular Interactions Governing Autoantigen Presentation in Type 1 Diabetes

Mobile Phone and Smartphone Technologies for Diabetes Care and Self-Management

Novel Risk Factors for Type 2 Diabetes in African-Americans